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Background: Long-term home mechanical ventilation (HMV) is usually initiated in hospital.
Admission to hospital has resource implications and may not be reimbursable in some health-
care systems.
Methods: Twenty-eight stable neuromuscular and chest wall disease patients with nocturnal
hypoventilation (transcutaneous carbon dioxide (TcCO2 >6.5 kPa), were randomised to start
HMV either as an outpatient (nZ 14, age range 12e62 years) or inpatient (nZ 14, age range
14e73 years). We compared effects of HMV on nocturnal and diurnal arterial blood gas
tensions, ventilator compliance, healthcare professional (HCP) contact time, and time in
hospital.
Results: Improvements in nocturnal arterial oxygen saturation (SaO2) and daytime PaO2 were
equivalent in both groups. Peak nocturnal TcCO2, improved in both groups; % time TcCO2
>6.5 kPa fell in the inpatient group and daytime PaCO2 decreased significantly (p < 0.05) in
the outpatient group. The mean (SD) inpatient stay was 3.8 (1.0) days, and the outpatient
attendance sessions 1.2 (0.4). HCP contact time including telephone calls was: inpatient 177
(99) min; outpatient 188 (60) min (pZ not significant); 2 month ventilator compliance was:
inpatient 4.32 (7); outpatient 3.92 (8) (pZ not significant) hours per night.
Conclusion: Outpatient initiation of HMV is feasible with equivalent outcome in the outpatient
and the inpatient groups.
ª 2008 Elsevier Ltd. All rights reserved.0 7351 8027; fax: þ44 20 7351 8911.
hs.uk (M. Chatwin).
8 Elsevier Ltd. All rights reserved.
Inpatient vs. outpatient initiation of NIV 1529Introduction
Home mechanical ventilation (HMV) is an effective treat-
ment for neuromuscular disease (NMD) and chest wall
disease patients with daytime hypercapnia, as it has been
shown to improve survival and quality of life.1e4 Initiation
of HMV in patients with daytime hypercapnia or nocturnal
desaturation is consistent with Consensus Conference
recommendations5 and American Thoracic Society state-
ment on the management of respiratory failure in
Duchenne muscular dystrophy (DMD) patients.6 More
recently Ward et al.7 investigated the timing of initiation of
HMV in NMD and chest wall disease patients. Their results
suggest that the optimum time for starting HMV is after the
onset of nocturnal hypoventilation as at 12 months, 70% of
patients randomised to control group had fulfilled the
criteria for HMV (daytime hypercapnia, recurrent chest
infections and increase in symptoms). Initiation of HMV
once nocturnal hypoventilation has developed allows
greater choice for the family on the timing of hospital
admission, and reduces the risk of acute uncontrolled
ventilatory decompensation.
HMV in Europe is often started in a hospital inpatient
setting.8 This has cost implications for the healthcare
purchaser/provider and the recipient.9 Non-acute hospital
admissions are often inconvenient for the patient, beds
may be unavailable, there is a risk of nosocomial infections
and patients and families inevitably lose time off work or
study.10 In addition, hospital wards may lack facilities for
patients with physical disabilities and for their carers/
family to stay. Initiation of HMV can be carried out with the
patient attending as an outpatient.11,12 However, the
effectiveness of outpatient set up of HMV has never been
systematically assessed or compared to inpatient initiation.
In this study we have tested the hypothesis that patients
with stable NMD and chest wall diseasewhowere initiated on
HMV due to nocturnal hypoventilation, in an outpatient
setting, are able to achieve similar control of sleep disor-
dered breathing, compared to those initiated on HMV in the
hospital ward as an inpatient, using a prospective rando-
mised controlled design. Primary outcomes measured were
daytime arterial blood gas (ABG) and night-time trans-
cutaneous carbon dioxide (TcCO2) tensions and arterial
oxygen saturation (SaO2). Secondary outcome measures
were quality of life, patient satisfaction, ventilator compli-
ance and healthcare professional (HCP) contact time.
Methods
Subjects
This study was approved by the local ethics committee, all
subjects and/or their parents gave consent. Patients aged
>11 years who fulfilled the inclusion/exclusion criteria
were sequentially recruited from the sleep laboratory and
ventilation clinic at the Royal Brompton Hospital and
randomised to inpatient or outpatient groups. Random-
isation was performed by an independent member of staff
(not involved in the study) using a stratified block ran-
domisation with a block size of 20. Inclusion criteria were
confirmed nocturnal hypoventilation (TcCO2 >6.5 kPa for>50% of the night, with symptoms of hypercapnia e.g.
frequent nocturnal turning, morning headache, poor appe-
tite in the morning or poor morning concentration). Patients
had to be clinically stable and free from chest infection or
bronchospasm in the previous 3 months. Individuals were
excluded if they had a history of, or current pneumothorax,
severe bulbar weakness, uncontrolled cardiac failure or
arrhythmia, or difficulty understanding the study protocol.
Peak cough flow was not measured and patients were not
taught or required cough assistance techniques at the time
of entrance or during the study period.
Measurements
The study protocol is shown in Fig. 1.
Arterial oxygen saturation (SaO2) and
transcutaneous carbon dioxide (TcCO2)
SaO2 was monitored by Nellcor N200 pulse oximeter (Tyco,
Gosport UK) and TcCO2 was measured using TINA TcCM CO2
electrode (TCM3, Radiometer, Copenhagen). The Radiom-
eter TINA system has been previously validated in our
laboratory by comparison with simultaneous arterial blood
gas sampling.13 ABG tension measurements were performed
before each sleep study in hospital.
Short-form 36 quality of life questionnaire (SF-36)
Patients were asked to complete the SF-36 questionnaire as
a generic measure of subjective health status14 at initiation
of HMV and at sleep study after 2 months.
Visual analogue scores (VAS)
VAS15 were used to assess the following areas: whether
starting HMV was judged easy or difficult; if the ventilator
was simple or difficult to use; whether patients felt they
had sufficient professional contact time; if given the choice
would they start as inpatient or outpatient; any change in
their symptoms; and the overall impression. A high score
indicates an unfavourable outcome.
Non-invasive ventilation initiation
For inpatient initiation, duration of the hospital stay was
from admission until the patient was competent in putting
the mask and headgear on, was able to operate, and sleep
for a period of several hours with HMV. Where appropriate,
carers were taught how to put the headgear on, and how to
operate the ventilator. During the admission, standardised
information and written educational handouts were
provided. These included contact numbers of hospital staff,
information on how to operate the ventilator, trouble-
shooting advice in case of ventilator malfunction or mask
problems, guidance on travelling with HMV and how to
clean the equipment. Patients completed the SF-36.16,17
The contact time of the HCP initiating HMV was recorded by
a bedside stop-watch.
For outpatient initiation, three visits were booked
a week apart. However, visits 2 and 3 were not mandatory if
Figure 1 Study protocol, showing transcutaneous carbon dioxide (TcCO2), oxygen saturation (SaO2), arterial blood gases (ABGs),
short-form SF-36, Quality of Life questionnaire (SF-36), Visual Analogue Score (VAS), standard education.
1530 M. Chatwin et al.the patient was making good progress. Patients also
received pre arranged telephone calls to assist with prog-
ress. During the outpatient visit, patients and carers were
taught to put the mask and headgear on, and how to
operate ventilator. During the outpatient sessions patients
were given the opportunity to lie down and settings were
adjusted over a 30e45 min period. Settings were increased
to ensure a good tidal volume was achieved by the patient
(ensuring good chest wall movement) or to the maximum
inspiratory pressure the patient could tolerate. Settings
were not calculated on a ml/kg basis as this is not possible
with all the pressure pre set ventilators used in this study.
SaO2 was monitored throughout. The same standardised
information and educational handouts were provided as for
the inpatient group. Patients completed the SF-36.16,17 The
length of the outpatient visit varied depending on the
individual’s progress. The contact time of the HCP initiating
HMV was recorded by stop-watch.
Mask leaks were not formally assessed to prevent bias
between the groups. Patients in both the inpatient and
outpatient groups had tried various masks to ensure they
were each discharged using the most comfortable and
appropriate mask.
Follow-up
Both groups returned to the hospital 2 months after starting
HMV for overnight TcCO2 and SaO2 monitoring on HMV, andABG analysis. After this sleep study, ventilator settings
were changed as appropriate to optimise nocturnal TcCO2
and SaO2 values and ventilator hours were downloaded.
Patients completed the SF-36 questionnaire16,17 and VAS as
previously described. Five-month and 12-month ABG
tensions were measured.
Statistical analysis
Data were tested for normality and analysed using either
parametric or non-parametric methods. We used a non-
inferiority test to demonstrate that outpatient set-up of
HMV produced comparable results i.e. was not significantly
worse compared to standard inpatient set-up. Based on
outcome data from a previous study from our group,7 11
patients per group (22 in total) would be required in order
to have 80% power to determine that the outpatient group
could be declared non-inferior to the inpatient group. This
is based on the primary outcome measure of the difference
in the reduction in TcCO2, using a standard deviation of
1.8 kPa and testing at the 5% significance level. The
outpatient arm would be declared non-inferior if the
reduction in TcCO2 in this arm was within at least 2 kPa of
the inpatient arm.
Difference from baseline sleep study values (overnight
time TcCO2 >6.5 kPa, peak TcCO2, percentage of the sleep
study SaO2 >90%, and lowest recorded SaO2) were tested
using a paired t-test and differences between inpatient
Inpatient vs. outpatient initiation of NIV 1531and outpatient groups were compared with unpaired
t-test.
For comparison of length of hospital stay, hospital visits,
HCP contact time and VAS data, unpaired t-testing was
used (i.e. the group means in the inpatient vs. outpatient
group were tested). For comparison of non-normally
distributed data the ManneWhitney Rank Sum Test was
applied.
All statistical analyses were carried using SigmaStat 3.0
or SPSS 12.0 for windows (SPSS Inc, Chicago, IL, USA).Results
Thirty-six patients were eligible for randomisation and 28
patients completed the study. There were 14 outpatients
(10 male), mean age 45 (range 12e69) years, and 14
inpatients (9 male), mean age 48 (range 14e73) years.
Diagnoses for the outpatient group were scoliosis (nZ 5),
spinal muscular atrophy type II (nZ 2), old polio (nZ 2),
diaphragm paralysis (nZ 2), Duchenne muscular dystrophy
(nZ 1), myotonic dystrophy (nZ 1) and multiple sclerosis
(nZ 1). Five of the 14 patients used wheelchairs. Out-
patient group mean  SD for baseline Hþ were
38.4  4.4 nmol/L, baseline PO2 10.37  2.0 kPa, Baseline
PCO2 5.9  1.0 kPa and baseline BE 3.0  5.4 nmol/L.
Diagnoses for the inpatient group were scoliosis (nZ 3),
spinal muscular atrophy type II (nZ 2), old polio (nZ 1),
diaphragm paralysis (nZ 2), Duchenne muscular dystrophy
(nZ 3), motor neurone disease (nZ 1), thoracoplasty
(nZ 1) and restrictive lung disease (nZ 1). Five of the 14
patients were wheelchair users. Inpatient group mean  SD
for baseline Hþ were 36.6  2.8 nmol/L, baseline PO2
10.0  1.6 kPa, Baseline PCO2 5.9  0.6 kPa and baseline BE
3.6  2.0 nmol/L. There was no significant difference in
daytime baseline ABG tensions between the outpatient and
inpatient groups. No patients in either the outpatient or the
inpatient group had obesity hypoventilation syndrome.
Ventilators used in the outpatient group were, BREAS PV403
(Breas, Sweden) nZ 6, VPAP STII (ResMed, Australia)
nZ 6, and NIPPY (B&D electrometrical, UK) nZ 2. Venti-
lators used in the inpatient group were, BREAS PV403
nZ 5, VPAP STII nZ 8, and BiPAP Harmony (Respironics,
USA) nZ 1. The choice of ventilator was influenced by
clinical indication, e.g. an NMD patient who is likely in time
to have increasing dependency on HMV was provided with
a ventilator that had a good battery life. The same venti-
lator starting pressures were used in both the outpatient
and inpatient groups (outpatient inspiratory pressure:
16  4 cmH2O; inpatient inspiratory pressure 16  4
cmH2O). No supplemental oxygen was entrained in either
group, and a back up rate of 15e20 breaths per minute was
set. Nasal masks were used wherever possible, however if
there was a substantial mouth leak or mouth breathing
a full face mask was provided.
Eight patients who were eligible to participate in the
study did not take part. One withdrew prior to being
randomised, and one died of an unrelated cause. Six
patients who started HMV elected not to continue with the
study (4 outpatients, 2 inpatients) within 2 weeks of being
initiated on HMV. Three patients, with chest wall disease,
have since gone on to recommence HMV and their resultsare not included in these data. Fourteen patients in each
limb completed the trial.
Sleep study results
Outpatient baseline peak overnight TcCO2 was
10.0  1.4 kPa. There was a significant reduction in peak
TcCO2 after 2 months of 1.4  1.9 kPa (pZ 0.04). Inpa-
tient baseline peak overnight TcCO2 was 9.5  1.7 kPa and
there was a significant decrease in peak TcCO2 from base-
line at 2 months of 1.5  2.2 kPa (pZ 0.04).There was no
significant difference in decrements between the outpa-
tient and the inpatient groups (pZ 0.5).
Outpatient baseline for the percentage of time the sleep
study TcCO2 was >6.5 kPa was 92  13%. There was
a reduction in the percentage of time the sleep study TcCO2
was >6.5 kPa from baseline at 2 months of 3.0  12%
(pZ 0.1). Inpatient baseline percentage of time the sleep
study TcCO2 was >6.5 kPa was 80  17%. There was
a significant reduction in the percentage of time the sleep
study TcCO2 was >6.5 kPa at 2 months of 29  37%
(pZ 0.02). There was no significant difference in these
changes between the outpatient and the inpatient groups
(pZ 0.2).
Outpatient baseline for the percentage of time the sleep
study SaO2 was >90% was 85  28%. There was an increase
in the percentage of time the sleep study SaO2 was >90%
from baseline at 2 months of 12  30% (pZ 0.06). Inpatient
baseline for the percentage of time the sleep study SaO2
was >90% was 93  7%. There was an increase in the
percentage of time the sleep study SaO2 was >90% from
baseline at 2 months of 4  7% (pZ 0.07). There was no
significant difference between the outpatient and the
inpatient groups (pZ 0.7).
Outpatient baseline for the lowest recorded overnight
SaO2 was 77  11%. There was a significant reduction in the
lowest recorded overnight SaO2 from baseline at 2 months
of 12  10% (pZ 0.003). Inpatient baseline for the lowest
recorded overnight SaO2 was 78  10%. Similarly there was
a significant reduction in the lowest recorded overnight
SaO2 from baseline at 2 months of 9  9% (pZ 0.006).
There was no significant difference between the outpatient
and the inpatient groups (pZ 0.8).
Day time arterial blood gas changes
Changes in daytime PaCO2 and PaO2 in each group are
shown in Table 1.
Length of stay and number of hospital visits
The median (range) length of stay for the inpatients was 4
(2e7) days, while outpatients attended for 1 (1e2) sessions.
There was no difference between outpatient and inpa-
tient groups for HCP contact time (outpatient, 3.13  0.9 h;
inpatient, 2.85  1.6 h; pZ 0.6).
No significant difference was found between outpatient
and inpatient groups for the average hours of ventilator use
per night (downloaded from software or the internal clock)
over the 2 month period after HMV initiation (outpatient
Table 1 Response to non-invasive ventilation; changes in diurnal oxygen and carbon dioxide tensions
Inpatient Outpatient Statistical difference
between inpatient and
outpatient group
Daytime PaCO2 Baseline 5.9  0.6 kPa 6.1  0.7 kPa
D from baseline at 2 months 0.1  0.6 kPa 0.2  0.5 kPa
D from baseline at 5 months 0.2  0.5 kPa 0.7  0.6 kPa
D from baseline at 12 months 0.1  0.5 kPa 0.7  0.9 kPa
p value 0.6 5 and 12 months p  0.03 0.04 at 5 months
0.06 at 12 months
Daytime PaO2 Baseline 9.8  1.6 kPa 10.0  1.5 kPa
D from baseline at 2 months 0.7  1.9 kPa 0.4  1.6 kPa
D from baseline at 5 months 1.8  1.4 kPa 1.4  1.4 kPa
D from baseline at 12 months 1.9  2.0 kPa 1.2  1.4 kPa
p value 5 and 12 months pZ 0.01 5 and 12 months pZ 0.02 0.6
1532 M. Chatwin et al.ventilator use, 3.9  2.6 h/night; inpatient ventilator use
4.3  2.7 h/night; pZ 0.6).
However, as may be expected with the design of the
study there was a significant difference in the amount of
time each group spent in hospital (p < 0.001). We employed
a measure of ‘units’; half a day spent in hospital equalling
one unit. Outpatients spent on average of 1 unit (1/2 a day)
(range 1e2 units). Inpatients spent on average of 8 units
(4 days) (range 4e14 units).
SF-36 results
The SF-36 generic measure of subjective health status
results is shown in Table 2. A low score indicates a poor
perceived health status and a score of 100 indicates an
excellent health status. Results for health status are shown
as a median and range. Recent work has suggested how
these results might be expressed as clinically significant
changes for patients.18 Table 2 indicates whether the
change in SF-36 score in each domain is likely to be asso-
ciated with a clinically significant impact. Importantly
there was no deterioration in any aspect of SF-36 health
status in either group.
VAS results
VAS results are shown in Fig. 2.Discussion
The main finding of this randomised study was that in
patients with nocturnal hypoventilation alone, it is possible
to initiate HMV as an outpatient. This is the first study in
NMD and chest wall disease comparing the effect of
inpatient versus outpatient provision of nocturnal HMV;
outpatient initiation of HMV is feasible, although outpa-
tients who are started on HMV will need close follow up to
ensure adequate control of nocturnal blood gases. The
improvements in SF-36 scores were similar in the two
groups and comparable to those previously reported.19,20Limitations of the study
The patients in this trial were very highly selected and
despite abnormal nocturnal blood gas tensions had a near
normal daytime PaCO2. Those with cognitive impairment or
severe bulbar weakness were excluded, as these individuals
may be more likely to experience problems with HMV21 and
need more intensive support. Importantly, we also
excluded unstable patients with uncontrolled hypercapnia
or those experiencing an acute exacerbation, so results
cannot be extrapolated to this population. We did not carry
out full polysomnography to assess effects on sleep archi-
tecture and arousals so we cannot comment on sleep
quality.
In our study 14 patients who were initiated on HMV as
inpatients and 14 patients who were initiated on HMV as
outpatients completed the study. Some patients in both the
inpatient and the outpatients had a ventilator compliance
that is lower than desired, although we do not know how
much HMV is needed and whether this varies from patient
to patient. One study20 found significant improvement in
arterial blood gas tensions only in those who used HMV for
>4 h per night. An explanation for the current results is
that these patients were advised to gradually acclimatise
to HMV and nightly use of HMV would have been greater at
the end of the study than the start; our data collected over
2 months did not take this into account. Our impression is
that outpatients increased night-time use more gradually
than inpatients. We also acknowledge that a wide variety
of non-invasive ventilators were used in this study,
however the distribution between groups was similar and
we do not believe this masks true differences. Many
hospitals use different ventilators within their service, and
no single make of ventilator leads to lower hours of
nocturnal use.
There is limited information as to why certain patients
who are offered HMV on evidence-based criteria refuse
treatment, or have poor adherence. In a previous study by
our group7 we found that 11% of patients with daytime
hypercapnia chose not to commence HMV. In the present
study 25% of patients with nocturnal hypercapnia alone,
who were randomised to receive HMV, declined treatment.
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Inpatient vs. outpatient initiation of NIV 1533At the conclusion of the study the total percentage of
patients who took up HMV was 82%. Criner et al.22 reported
similar findings, in that a quarter of patients with restric-
tive disorders and half of patients with COPD were unable
to use HMV long term.
Patients who withdrew from the present study were
those with scoliosis and mild nocturnal hypoventilation
(TcCO2 >6.5 kPa). They had symptoms of morning head-
ache but saw the use of HMV as an inconvenience rather
than a means to symptomatic improvement. An explana-
tion for this may be that patients with scoliosis have
a slower evolution of respiratory failure. They may also
acclimatise to having a slightly higher PaCO2 compared to
NMD patients, or could be more sensitive to sleep
disruption by HMV.
Significance of the findings
The primary aim of this study was to compare inpatient
versus outpatient initiation of HMV on sleep study results
and to investigate patient satisfaction. However, having
found that initiation of HMV as an outpatient was feasible,
an obvious further question is: what are the economic and
organisational implications? The cost of the ventilator,
mask and circuitry was the same for both inpatients and
outpatients, and there were no differences in the number
of journeys to and from the hospital, although this would be
greater if numerous outpatient sessions were required.
There were also no differences in the amount of HCP
contact time. The main difference between inpatient and
out patient set-up of HMV was the use of hospital facilities,
i.e. bed occupancy, general care, meals and medication
costs. An inpatient admission may block an acute bed;
although most centres that provide HMV also have a sleep
study service. Sleep study beds are often empty during the
day, and this may be a useful and safe area to commence
HMV, providing facilities for patients with physical disabil-
ities are available. Patients can lie down and can spend
time with their carer practising and building confidence
using HMV before going home. In the present study we did
not perform a detailed cost analysis. However, the results
suggest that outpatient provision of HMV, in certain
patients, could be cost effective, and may prevent delays in
admission if acute beds are busy. The outpatients rated the
option of being set up as an outpatient more convenient
than an inpatient admission, despite the fact that they
knew in advance they might need a greater number of
hospital visits, and would not have night-time support from
the nursing staff. No patient reported anxiety in their first
night of use at home.
There was no objective difference between the groups
in professional contact time and written information
received by the two groups. Our centre has a team of HCP
who are specially trained in the initiation of HMV. This
enables them to anticipate and identify difficulties early
and provide information to prevent them escalating into
a major problem. It also means they can solve problems by
phone call, which has been shown to be effective in certain
groups of respiratory patients.23 The fact that this study
took place in a highly specialised centre means that the
results may not be transferable to centres without similar
experience and organisation.9
Figure 2 VAS scores in response to the questions. High scores indicated an unfavourable outcome.
1534 M. Chatwin et al.The results from this study indicate that patients who
have a preference for either an inpatient or outpatient
initiation of HMV can be allowed to choose. Factors to be
taken into consideration are distance required to travel
to the centre initiating HMV, whether the patient lives
alone, whether they have cognitive or bulbar problems, if
they have carers, how anxious they are, and whether
carers can cope regardless of the competence of the
patient.
In conclusion, in stable patients with nocturnal hypo-
ventilation and modest daytime hypercapnia, comparable
results were seen for inpatient and outpatient initiation of
HMV although the inpatient group was more effectively
ventilated initially. Outpatient provision of HMV in stable
patients was preferred by patients and their families, and
was likely to have been less expensive. All patients need
adequate follow-up to optimise symptom control, treat-
ment adherence and compliance.
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